ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,269, issued on April 7, was assigned to Solvonis Therapeutics Ireland Holdings Ltd. (Dublin).
"Morpholine-like monoamine releasers" was invented by Alan Borthwick (London), Fabrizio Micheli (Desenzano del Garda, Italy), Alessandra Micoli (Verona, Italy), Ferruccio Palazzesi (Verona, Italy), Agostino Cianciulli (Verona, Italy), Robin Tyacke (London) and David Nutt (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are certain therapeutic substituted heterocyclic bridged ring compounds, including substituted morpholine, thiomorpholine, and piperidine compounds and their homologues, having various advantages over current compounds ...